FDA resists calls to pull abortion pill off market
22400
The government said yesterday a controversial abortion pill is safe enough to remain on the market, despite a third death and a grieving father&#39;s plea.
128818
A federal judge on Wednesday issued a preliminary injunction barring enforcement of an Ohio law that requires doctors to follow FDA guidelines when dispensing drugs for medical abortions, the Cincinnati Post reports.
545492
Is the US Food &amp; Drug Administration failing? That was the testimony of one senior FDA official last week concerning Merck&#39;s withdrawal of the Vioxx anti-pain drug.
314959
Groups say the abortion drug Mifeprex or RU-486 is no less dangerous despite a newly revised warning label of the drug&#39;s negative side effects.
672684
fter resisting calls for nearly a year that National Institutes of Health scientists end private consulting arrangements with pharmaceutical companies, the agency&#39;s director is expected
442455
Anti-abortion groups are urging President Bush to withdraw his nominee to head the Food and Drug Administration, angry that the agency may allow nonprescription sales of the morning-after pill.
31437
The recent Vioxx withdrawal and testimony from an FDA insider accusing the agency of failing to protect public health are fueling such heightened concern over drug safety that valuable medicines could be kept from patients, doctors said on Friday.
193540
The US Food and Drug Administration yesterday sought to distance itself from remarks by one of its top safety officials that raised concerns about key drugs made by Astrazeneca and Glaxo Smithkline.
108234
WASHINGTON -- An abortion pill implicated in the death of an 18-year-old California woman last fall will add new warnings linking RU-486 to the risk of serious bacterial infection.
102166
U.S. regulators on Friday delayed a  decision on whether to approve over-the-counter sales of a Barr  Pharmaceuticals "morning-after pill" to prevent pregnancy,  prompting a lawsuit from a women's rights group.
629811
The U.S. House of Representatives ignored a White House veto threat and voted on Thursday to allow government donations of contraceptives to family planning groups outside the United States even though they engage in abortion activities.
237594
As the FDA approves the morning-after pill for over-the-counter sales to adults, conservatives beat up on the federal agency and the drugmaker begins its push to make Plan B available to younger women
258753
WASHINGTON -- The Food and Drug Administration is preventing an agency scientist from presenting the largest, most up-to-date study of popular painkillers like Bextra, Celebrex and Vioxx during an FDA meeting next week on heart risks posed by the drugs, a US senator charged.
173477
TUESDAY, Nov. 16 (HealthDayNews) -- U.S. Food and Drug Administration officials insisted Tuesday that medical evidence, and not political pressure from conservative groups, prompted their decision Monday to order the most stringent safety labeling for RU-486, the abortion pill.
72787
WASHINGTON Nov 16, 2004 - The government on Tuesday said a controversial abortion pill is safe enough to remain on the market, despite a third death and a grieving father&#39;s plea.
515226
A federal judge denied a request by Pfizer (nyse: PFE - news - people ) to halt competitors&#39; sales of gabapentin, a generic form of Pfizer&#39;s Neurontin epilepsy drug.
597746
Industry analysts are predicting US regulators this month will refuse to approve Merck &amp; Co.&#39;s new arthritis drug until at least 2006 because of heart attacks linked to its recalled sister drug Vioxx.